These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 11647962)
1. Prize in an unusual lottery: a scarce experimental drug. Lewin T N Y Times Web; 1994 Jan; ():A1, A17. PubMed ID: 11647962 [No Abstract] [Full Text] [Related]
2. Rationing scarce drugs has some questioning fairness and ethics. Chase M Wall St J (East Ed); 1998 Sep; ():B1. PubMed ID: 11648111 [No Abstract] [Full Text] [Related]
3. Patients with multiple sclerosis enter lottery. McBride G BMJ; 1993 Oct; 307(6910):958. PubMed ID: 11643182 [No Abstract] [Full Text] [Related]
4. Clinical AIDS research that evaluates cost effectiveness in the developing world. Christakis NA; Lynn LA; Castelo A IRB; 1991; 13(4):6-8. PubMed ID: 11651482 [No Abstract] [Full Text] [Related]
6. Ethical dilemmas with studies in less-developed countries: AIDS research trials. Barry M IRB; 1991; 13(4):8-9. PubMed ID: 11651483 [No Abstract] [Full Text] [Related]
7. Ethical factors in the allocation of experimental medical therapies: the chronic left ventricular assist system. Parker LS; Arnold RM; Meisel A; Siminoff LA; Roth LH Clin Res; 1990 Oct; 38(3):537-44. PubMed ID: 2279367 [No Abstract] [Full Text] [Related]
9. Medicaid payment ordered for drug for schizophrenia. Freudenheim M N Y Times Web; 1991 May; ():1, 10. PubMed ID: 11647896 [No Abstract] [Full Text] [Related]
10. Medical necessity, AIDS, and the law. Schultz GP; Pormenter CA St Louis Univ Public Law Rev; 1990; 9(2):379-420. PubMed ID: 11651112 [No Abstract] [Full Text] [Related]
11. In business to treat cancer. Henig RM N Y Times Mag; 1986 Nov; ():68, 70, 78, 80+. PubMed ID: 11647805 [No Abstract] [Full Text] [Related]
12. Experimental drugs: more of them, but they're no longer free. Caplan J Hastings Cent Rep; 1987 Jun; 17(3):3. PubMed ID: 11644019 [No Abstract] [Full Text] [Related]
13. FDA's new rule on treatment use and sale of investigational new drugs. Levine RJ IRB; 1987; 9(4):1-4. PubMed ID: 11649946 [No Abstract] [Full Text] [Related]
14. Patients paying to be subjects in brain study. Kolata G N Y Times Web; 1992 May; ():1, 24. PubMed ID: 11646930 [No Abstract] [Full Text] [Related]
15. Medical insurance payments and patients involved in research. Holder AR IRB; 1994; 16(1-2):19-22. PubMed ID: 11652323 [No Abstract] [Full Text] [Related]
16. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials. Weijer C IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912 [No Abstract] [Full Text] [Related]
17. Women resist trials to test marrow transplants. Kolata G N Y Times Web; 1995 Feb; ():C8. PubMed ID: 11647058 [No Abstract] [Full Text] [Related]
18. Waiting for interferon: what happens when people's hopes run ahead of the scientific method. Fox C Harpers (N Y N Y); 1982 Sep; 265(1588):32-38, 42-46. PubMed ID: 11658396 [No Abstract] [Full Text] [Related]
19. Report of the Massachusetts Task Force on Organ Transplantation. Massachusetts. Task Force on Organ Transplantation Law Med Health Care; 1985 Feb; 13(1):8-26. PubMed ID: 11643869 [No Abstract] [Full Text] [Related]
20. Considering experimentation and elusive truth: informed consent made difficult. Brodeur D Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444 [No Abstract] [Full Text] [Related] [Next] [New Search]